UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of the American College of Cardiology, ISSN 0735-1097, 2011, Volume 57, Issue 22, pp. 2244 - 2254
Cardiovascular | Internal Medicine | ventricular arrhythmia | antiarrhythmia agents | catecholaminergic polymorphic ventricular tachycardia | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Medical sciences | Cardiac dysrhythmias | Arrhythmias, Cardiac - prevention & control | Flecainide - administration & dosage | Tachycardia, Ventricular - drug therapy | Anti-Arrhythmia Agents - pharmacology | Humans | Middle Aged | Male | Flecainide - pharmacology | Anti-Arrhythmia Agents - therapeutic use | Anti-Arrhythmia Agents - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Exercise Test | Defibrillators, Implantable | Adolescent | Adult | Female | Aged | Retrospective Studies | Child | Flecainide - therapeutic use | Heart failure | Medical colleges | Care and treatment | Implants, Artificial | Prosthesis | Cardiac patients | Ventricular tachycardia | Cardiology | Flecainide | Medical genetics | Children | Health aspects | Cardiovascular agents | Cardiac arrhythmia | Heart attacks | Exercise | Defibrillators | Index Medicus | Abridged Index Medicus
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 5/2015, Volume 71, Issue 5, pp. 549 - 567
Generic drugs | Antiarrhythmic drugs | Biomedicine | Bioequivalence | Narrow therapeutic index | Safety | Pharmacology/Toxicology | Flecainide | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Dose-Response Relationship, Drug | Flecainide - adverse effects | Drugs, Generic - adverse effects | Drugs, Generic - pharmacokinetics | Drugs, Generic - pharmacology | Humans | Flecainide - pharmacokinetics | Flecainide - pharmacology | Practice Guidelines as Topic | Therapeutic Equivalency | Drugs | Health aspects | Cardiac arrhythmia | Side effects | Pharmacology | Index Medicus | Life Sciences | Bioengineering | Pharmaceutical sciences | Review
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 17, pp. 1587 - 1595
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | General aspects | Cardiac dysrhythmias | Biological and medical sciences | Treatment. General aspects | Other treatments | Medical sciences | Tumors | Follow-Up Studies | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Propafenone - adverse effects | Cost of Illness | Male | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Atrial Fibrillation - surgery | Flecainide - adverse effects | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - diagnosis | Intention to Treat Analysis | Statistics, Nonparametric | Quality of Life | Female | Aged | Propafenone - therapeutic use | Catheter Ablation - adverse effects | Atrial Fibrillation - diagnosis | Electrocardiography, Ambulatory | Flecainide - therapeutic use | Care and treatment | Usage | Atrial fibrillation | Patient outcomes | Anti-arrhythmia drugs | Radiofrequency ablation | Dosage and administration | Drug therapy | Fees & charges | Cardiac arrhythmia | Stroke | Arrhythmia | Platelet-activating factor | Cardiovascular disease | Grants | Patients | Ablation | Catheters | Manuscripts | Tamponade | Fibrillation | Motivation | Electrocardiography | Drug dosages | Antiarrhythmic agents | Veins & arteries | Index Medicus | Abridged Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
European journal of pharmacology, ISSN 0014-2999, 09/2012, Volume 691, Issue 1-3, p. 173
Journal Article
Biomedical chromatography, ISSN 0269-3879, 10/2016, Volume 30, Issue 10, pp. 1541 - 1548
flecainide acetate | TLC‐densitometry | flecainide impurity B | flecainide impurity D | HPLC | TLC-densitometry | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Pharmacology & Pharmacy | Chemistry, Analytical | Science & Technology | Reference Standards | Reproducibility of Results | Chromatography, High Pressure Liquid - methods | Chromatography, Thin Layer - methods | Anti-Arrhythmia Agents - analysis | Flecainide - analysis | Spectrophotometry, Ultraviolet | Esters | Flecainide | Methods | High performance liquid chromatography | Index Medicus
Journal Article
Ultrasound in obstetrics & gynecology, ISSN 0960-7692, 09/2015, Volume 46, Issue S1, pp. 197 - 197
Journal Article
Néphrologie & thérapeutique, ISSN 1769-7255, 12/2006, Volume 2, Issue 7, p. 442
Journal Article
JACC: Case Reports, ISSN 2666-0849, 04/2020, Volume 2, Issue 4, pp. 595 - 597
Journal Article
Heart rhythm, ISSN 1547-5271, 2015, Volume 12, Issue 3, pp. 596 - 603
Cardiovascular | Ventricular arrhythmia | Mutation | Flecainide | Andersen-Tawil syndrome | Long QT | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Follow-Up Studies | Syncope - epidemiology | Flecainide - administration & dosage | Humans | Young Adult | Ventricular Premature Complexes - physiopathology | Adult | Ventricular Premature Complexes - epidemiology | Andersen Syndrome - complications | Andersen Syndrome - physiopathology | Administration, Oral | Tachycardia, Ventricular - drug therapy | Heart Arrest - epidemiology | Tachycardia, Ventricular - etiology | Potassium Channels, Inwardly Rectifying - genetics | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Flecainide - adverse effects | Syncope - prevention & control | Tachycardia, Ventricular - physiopathology | Ventricular Premature Complexes - drug therapy | Heart Arrest - prevention & control | Adolescent | Andersen Syndrome - genetics | Electrocardiography, Ambulatory | Flecainide - therapeutic use | Sects | Care and treatment | Genetic aspects | Arrhythmia | College graduates | Heart | Medical research | Tachycardia | Medicine, Experimental | Index Medicus
Journal Article
British journal of pharmacology, ISSN 0007-1188, 08/2016, Volume 173, Issue 15, pp. 2446 - 2459
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Calcium - metabolism | Sarcoplasmic Reticulum - drug effects | Humans | Cells, Cultured | Rats | Male | Ryanodine Receptor Calcium Release Channel - metabolism | Flecainide - pharmacology | Structure-Activity Relationship | Rats, Sprague-Dawley | Dose-Response Relationship, Drug | Flecainide - analogs & derivatives | Animals | Myocytes, Cardiac - drug effects | HEK293 Cells | Myocytes, Cardiac - metabolism | Flecainide - chemistry | Molecular Structure | Sarcoplasmic Reticulum - metabolism | Physiological aspects | Tachycardia | Flecainide | Analysis | Calcium | Rodents | Index Medicus | Research Papers | Research Paper
Journal Article
British journal of pharmacology, ISSN 0007-1188, 04/2018, Volume 175, Issue 8, pp. 1260 - 1278
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Tachycardia | Flecainide | Analysis | Atrial fibrillation | Heart | Myocardial infarction | Conduction | Cardiac arrhythmia | Animal models | Propagation velocity | Ryanodine receptors | Action potential | Activation | Inactivation | Channels | Fibrillation | Sodium channels (voltage-gated) | Heart diseases | Calcium channels | Calcium (intracellular) | Deactivation | Pharmacology | Substrates | Infarction | Ventricle | Cardiovascular diseases | Binding sites | Calcium ions | Index Medicus | Themed Section | Review
Journal Article